gilead-sciences

Gilead launches hep C drug Sovaldi in China at one-fifth of US price

November 29, 2017
Research and Development, Sales and Marketing China, Gilead, hepatitis C, pharma, sovaldi

Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it …

scott_gottlieb

FDA unveils guidelines to help generic medical device versions reach the market

November 28, 2017
Research and Development, Sales and Marketing FDA, Mylan, Scott Gottlieb, auto injector, auto-injector, epipen, pharma

The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of last summer, continuing to grab …

mr058666-web

Merck KGaA and Pfizer’s Bavencio fails at Phase 3 in gastric cancer

November 28, 2017
Research and Development Bavencio, Cancer, Merck, Pfizer, pharma

Merck KGaA and Pfizer have been rocked by the news that their jointly-developed anti-PD-L1 antibody failed to meet its primary …

bribe

Trio, including former Novartis exec, accused of bribery to the tune of over HK$1.5 million

November 28, 2017
Manufacturing and Production, Sales and Marketing Novartis, bribery, illegal

A trio, including a former Senior Medical Representative at Novartis, have been charged over allegedly conspiring to offer and accept …

800px-cancer_cells_1

University of Virginia researchers identify new target in triple-negative breast cancer

November 28, 2017
Manufacturing and Production, Research and Development University of Virginia, breast cancer, pharma, triple-negative breast cancer

Researchers at the University of Virginia claim they have discovered a new target for triple-negative breast cancer, a notoriously aggressive …

NICE refuses Eisai’s breast cancer drug in new indication

November 28, 2017
Manufacturing and Production, Sales and Marketing Cancer, Eisai, Halaven, NICE, breast cancer, pharma

NICE has announced that it has rejected Eisai’s Halaven (eribulin) through draft guidance advising not to use the drug in …

better_q_image

Intelligent Automation in Pharmacovigilance

November 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, pharmacovigilance, primevigilance

PrimeVigilance is pleased to announce their collaboration with the International Society of Pharmacovigilance (ISoP) on the upcoming seminar, organised by …

eylea-product-box-md

Regeneron forced to drop Eylea combo, advantage Novartis

November 27, 2017
Manufacturing and Production, Research and Development Eylea, Novartis, Regeneron, biotech, drugs, pharma, pharmaceutical

Novartis released Phase 3 data on its leading candidate for wet age-related macular degeneration (AMD) drug and it caused a …

Recipharm equips a further three facilities for US serialisation

November 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in …

2017-vecms_emailbanner_accel_600x200_v3

Veeva European Commercial & Medical Summit

November 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva

The Veeva European Commercial & Medical Summit will begin tomorrow, seeing more than 800 industry leaders convene at the Marriot …

hiv_aids

The global HIV/AIDS movement

November 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AIDS, HIV, International HIV/AIDS Alliance

Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to …

Bayer’s $175 million pneumonia drug fails at phase 3

November 27, 2017
Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma

Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …

astrazeneca_logo_building

AstraZeneca continues pivot to east with Chinese collaboration

November 27, 2017
Medical Communications, Sales and Marketing AstraZeneca, biotech, drugs, pharma, pharmaceutical

It’s been a rocky year for AstraZeneca, it has scored some major successes yet its year has been marred by …

shutterstock_138095450

Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals

November 27, 2017
Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma

President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …

houses-of-parliament-1055056_960_720

UK government unveils pharma research HQ coup

November 27, 2017
Medical Communications, Sales and Marketing MSD, biotech, drugs, life sciences, pharma, pharmaceutical

The UK government’s Autumn Budget struck a gloomy note for the economy, with figures pointing towards low productivity and the …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …

crowd-2045498_960_720

Different gene mutations in multiple myeloma depending on ancestry

November 24, 2017
Medical Communications, Research and Development biotech, drugs, multiple myeloma, pharma, pharmaceutical

Researchers, based in the US, have conducted a large-scale collection of publicly available data and found that significant differences can …

shutterstock_274590824

Ex-Pharmacy Compliance Director pleads guilty to introducing illegal drugs into the market

November 24, 2017
Medical Communications Department of Justice, FDA, pharma

Caprice Bearden, a 63-year old ex-Director of Compliance for an Indiana-based Pharmakon, has been found guilty of introducing adulterated drugs …

astrazeneca_sign_sky

AZ partners with Combinations Alliance to test drug in cancer

November 24, 2017
Medical Communications, Research and Development AstraZeneca, biotech, drugs, pharma, pharmaceutical

A clinical trial is to be launched to test AstraZeneca’s experimental drug, AZD1775, for the treatment of head and neck …

The Gateway to Local Adoption Series

Latest content